Agave Biomedical Industries
Biomedical research for cures
Agave Biomedical Industries is a research company advancing drug discovery, genomics, diagnostics, and public health to find better ways to treat cancer, Parkinson's, dementia, and other diseases that touch millions of lives.
Accelerating cures through rigorous, compassionate science
We believe the most promising medical breakthroughs emerge when cutting-edge technology meets deep respect for human biology. Our mission is to discover, develop, and deliver therapies that improve survival, slow progression, and restore quality of life for patients and families facing serious illness.
Rigorous research
Data-driven hypotheses, validated methods, and transparent reporting.
Patient-centered
Every discovery is measured by its impact on real people's lives.
From molecule to medicine
Our interdisciplinary programs span the full spectrum of biomedical innovation, from foundational genomics to clinical translation.
Drug Discovery & Compatibility
We identify novel therapeutic candidates and model drug-drug interactions to ensure safer, more effective combination therapies.
Explore Drug Discovery & Compatibility
Genomics & Precision Medicine
From whole-genome analysis to target identification, we translate genetic insights into personalized treatment strategies.
Explore Genomics & Precision Medicine
Personalized Medicine & Genetics
Applying genetic insights to guide prevention, diagnosis, and treatment decisions for cancer, neurology, and neurodegeneration.
Explore Personalized Medicine & Genetics
Diagnostics & Biomarkers
Early detection saves lives. We develop sensitive diagnostic platforms and biomarker panels for earlier, more accurate disease identification.
Explore Diagnostics & Biomarkers
Public Health & Global Impact
Our epidemiology and outcomes research teams work to make advanced therapies accessible and equitable around the world.
Explore Public Health & Global Impact
Neurology, Oncology & Neurodegeneration
We focus on high-burden diseases such as cancer, Parkinson's, dementia, and epilepsy, exploring mechanisms to slow, stop, or control disease progression.
Explore Neurology, Oncology & Neurodegeneration
Artificial Intelligence in Drug Refinement
We use AI to compare, prioritize, and refine drug candidates for common and rare diseases, grounded in genetics and validated in the laboratory.
Explore Artificial Intelligence in Drug Refinement
Drug Comparisons by Disease
Disease by disease comparisons of therapeutic classes, showing how genetic differences change which medicines are likely to work.
Explore Drug Comparisons by Disease
Rare Disease Research
Monogenic conditions and gene therapy, where a single causal gene tells us exactly what a treatment needs to correct.
Explore Rare Disease Research
Natural Product Chemistry
Inspired by resilient organisms like the agave, we investigate bioactive compounds from natural sources as starting points for new medicines.
Explore Natural Product ChemistryAgave Biomedical Industries
Founded with a commitment to resilient, patient-first research, Agave Biomedical operates at the intersection of biology, technology, and public good. Like the agave plant that thrives in challenging environments, we pursue durable solutions to diseases that have long resisted easy answers.
Our partners include academic medical centers, global health organizations, and biopharma collaborators who share our belief that every patient deserves access to the next generation of treatments.
Fund the research
Every contribution goes directly toward our cross-research gene therapy work and the tools that bring discoveries closer to patients.
Payments are processed securely. Donations are not tax-deductible unless otherwise stated.
Partner with us on the next innovation of medicine
Whether you are a researcher, clinician, investor, or patient advocate, we would love to hear from you.